세계의 동물 진단 시장 : 제품 유형, 동물 유형, 검사 카테고리, 질병 유형, 최종 용도별 - 예측(2025-2030년)

The Veterinary Diagnostic Market was valued at USD 5.48 billion in 2023, expected to reach USD 6.24 billion in 2024, and is projected to grow at a CAGR of 15.24%, to USD 14.80 billion by 2030.

The veterinary diagnostic market encompasses a broad range of technologies, services, and products used to diagnose diseases in animals, crucial for maintaining animal health, ensuring food safety, and facilitating effective veterinary care. The necessity of veterinary diagnostics is underscored by the increasing prevalence of animal diseases, greater awareness regarding pet healthcare, and rising livestock health management requirements. Applications span across molecular diagnostics, immunodiagnostics, clinical biochemistry, and hematology, serving end-users such as veterinary hospitals, diagnostic laboratories, and research institutions. Market growth is driven by factors like advancements in diagnostic technologies, a growing pet population, and heightened veterinary healthcare expenditure. Opportunities lie in the expansion of point-of-care testing, increasing demand for rapid and accurate diagnostic services, and development of innovative diagnostic tools, such as portable devices and advanced imaging techniques. Furthermore, the integration of artificial intelligence and machine learning in diagnostics offers expansive potential. However, limitations include high costs associated with diagnostic procedures and instruments, regulatory challenges, and the lack of skilled professionals in developing regions which may impede market penetration. Key challenges also revolve around standardization issues and ensuring consistent quality amidst varying regional economic conditions. In terms of innovation, focusing on developing cost-effective and rapid testing solutions, wearable health monitoring devices for animals, and enhanced data management systems for veterinary diagnostics could be pivotal. Insights into the market suggest a competitive landscape characterized by frequent collaborations and partnerships aimed at broadening product portfolios and technological capabilities. To capitalize on emerging opportunities, companies should invest in research and development, fostering partnerships with academic institutions for cutting-edge innovations, and emphasize user-friendly, scalable solutions to cater to wider geographical markets. Understanding consumer needs and aligning product developments accordingly will be critical in navigating this evolving market landscape effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Diagnostic Market

The Veterinary Diagnostic Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in pet ownership and enhanced awareness about animal health
  • Increasing incidence of animal diseases in economies
  • Surge in animal healthcare expenditure coupled with rising disposable income
• Market Restraints
  • High cost associated with veterinary diagnostic testing
• Market Opportunities
  • Introduction of pet insurance and advanced development of new diagnostic assay
  • Emerging use of in vitro diagnostic tests and the rising number of veterinary laboratories
• Market Challenges
  • Lack of standardized tests and dearth of veterinarians in economies

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Diagnostic Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Diagnostic Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Diagnostic Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Diagnostic Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Diagnostic Market

A detailed market share analysis in the Veterinary Diagnostic Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Diagnostic Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Diagnostic Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Diagnostic Market

A strategic analysis of the Veterinary Diagnostic Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Agrolabo S.p.A., Bio-Rad Laboratories, Inc., Biogal Galed Labs, BioMerieux S.A., BioNote, Inc., Demeditec Diagnostics GmbH, Eurofins Technologies, Fassisi GmbH, FUJIFILM Holdings Corporation, Heska Corporation, IDEXX Laboratories, Inc., IDvet, Late Dr. (Major) S.K., Neogen Corporation, Nisseiken Co., Ltd, Qiagen N.V., Randox Laboratories, Ltd., Shenzhen Bioeasy Biotechnology Co., Ltd., Shenzhen Mindray Animal Medical Technology Co., Ltd., SKYER, Inc., Skyla Corporation, Thermo Fisher Scientific Inc., Vimian Group AB, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Reagents & Kits, Instruments & Devices, and Software & Services.
• Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats and Dogs. The Livestock Animals is further studied across Cattle, Poultry, and Swine.
• Based on Testing Category, market is studied across Analytical Services, Bacteriology, Diagnostic Imaging, Immunoassays, Molecular Diagnostics, Parasitology, Pathology, Serology, and Virology.
• Based on Disease Type, market is studied across General Ailments, Hereditary, Congenital & Acquired Diseases, Infectious Diseases, Non-Infectious Diseases, and Structural & Functional Diseases.
• Based on End-Use, market is studied across Point-of-Care/In-House Testing, Research Centers & Universities, Veterinary Hospitals & Clinics, and Veterinary Reference Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in pet ownership and enhanced awareness about animal health
    • 5.1.1.2. Increasing incidence of animal diseases in economies
    • 5.1.1.3. Surge in animal healthcare expenditure coupled with rising disposable income
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with veterinary diagnostic testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of pet insurance and advanced development of new diagnostic assay
    • 5.1.3.2. Emerging use of in vitro diagnostic tests and the rising number of veterinary laboratories
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardized tests and dearth of veterinarians in economies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Consumables, reagents, and kits providing accuracy and speed in diagnosis
  • 5.2.2. Animal Type: Significant adoption of veterinary diagnostics for livestock animals health management
  • 5.2.3. Disease Type: Veterinary vaccines are primarily utilized to reduce the risk of infectious diseases in animals
  • 5.2.4. End-Use: Potential utilization of veterinary diagnostic in veterinary hospitals & clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Diagnostic Market, by Product

• 6.1. Introduction
• 6.2. Consumables, Reagents & Kits
• 6.3. Instruments & Devices
• 6.4. Software & Services

7. Veterinary Diagnostic Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animals
  • 7.2.1. Cats
  • 7.2.2. Dogs
• 7.3. Livestock Animals
  • 7.3.1. Cattle
  • 7.3.2. Poultry
  • 7.3.3. Swine

8. Veterinary Diagnostic Market, by Testing Category

• 8.1. Introduction
• 8.2. Analytical Services
• 8.3. Bacteriology
• 8.4. Diagnostic Imaging
• 8.5. Immunoassays
• 8.6. Molecular Diagnostics
• 8.7. Parasitology
• 8.8. Pathology
• 8.9. Serology
• 8.10. Virology

9. Veterinary Diagnostic Market, by Disease Type

• 9.1. Introduction
• 9.2. General Ailments
• 9.3. Hereditary, Congenital & Acquired Diseases
• 9.4. Infectious Diseases
• 9.5. Non-Infectious Diseases
• 9.6. Structural & Functional Diseases

10. Veterinary Diagnostic Market, by End-Use

• 10.1. Introduction
• 10.2. Point-of-Care/In-House Testing
• 10.3. Research Centers & Universities
• 10.4. Veterinary Hospitals & Clinics
• 10.5. Veterinary Reference Laboratories

11. Americas Veterinary Diagnostic Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Veterinary Diagnostic Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Diagnostic Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Royal Canin Collaborated with GekkoVet to Bring AI-Powered Solution For Vets
  • 14.3.2. IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio
  • 14.3.3. Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agrolabo S.p.A.
• 2. Bio-Rad Laboratories, Inc.
• 3. Biogal Galed Labs
• 4. BioMerieux S.A.
• 5. BioNote, Inc.
• 6. Demeditec Diagnostics GmbH
• 7. Eurofins Technologies
• 8. Fassisi GmbH
• 9. FUJIFILM Holdings Corporation
• 10. Heska Corporation
• 11. IDEXX Laboratories, Inc.
• 12. IDvet
• 13. Late Dr. (Major) S.K.
• 14. Neogen Corporation
• 15. Nisseiken Co., Ltd
• 16. Qiagen N.V.
• 17. Randox Laboratories, Ltd.
• 18. Shenzhen Bioeasy Biotechnology Co., Ltd.
• 19. Shenzhen Mindray Animal Medical Technology Co., Ltd.
• 20. SKYER, Inc.
• 21. Skyla Corporation
• 22. Thermo Fisher Scientific Inc.
• 23. Vimian Group AB
• 24. Virbac S.A.
• 25. Zoetis Inc.